Where I see patients (2)
Selected research
- 
							Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.
							Advances in therapy
- 
							Brodalumab: Seven-Year US Pharmacovigilance Report.
							Dermatology and therapy
- 
							Neurocosmetics are cosmetics, which mean that they could have effects only on skin.
							Clinics in dermatology
 
					
				
 
														 
														 
														 
														 
														 
				
			